More than Expectorant: New Scientific Data on Ambroxol in the Context of the Treatment of Bronchopulmonary Diseases

Journal Title: Journal of Intensive and Critical Care - Year 2017, Vol 3, Issue 3

Abstract

Background:Ambroxol has been established for decades in the treatment of acute and chronic respiratory diseases. A reassessment of the benefit-risk was conducted recently. Objective: What new scientific data, relevant for the treatment of bronchopulmonary diseases, were published in the last decade? Method: Systematic literature search via http://www.pubmed.gov with the search term “ambroxol”, covering the publication period from 2006 to 2015. Nonrelevant publications were excluded manually. Results: 64 relevant publications could be identified covering both, clinical and preclinical research. Conclusion: The traditional indication of ambroxol as an expectorant is confirmed but new results revealed a better understanding of the various mechanisms of action of ambroxol and the benefits for special patient populations. The available data suggest the use of ambroxol as an adjuvant in anti-infective therapy, particularly in case of infections with biofilm-producing pathogens. Lungprotective properties are discussed in both infants and severely ill adult patients. First results in rare diseases, such as lysosomal storage disorders, show a potential benefit of ambroxol. However, final evidence for the clinical relevance in this special field has yet to be provided.

Authors and Affiliations

Manuel Plomer

Keywords

Related Articles

Effect of High-Dose Intravenous Immunoglobulin Administration on the Levels of Interleukin-6 in Patients with Sepsis

Background: Intravenous immunoglobulin (IVIG) is administered to patients with sepsis to improve clinical outcomes. Here, we report the effectiveness of highdose IVIG therapy in patients with sepsis admitted to a teachin...

A Third of Perioperative Blood Transfusions in the ICU Does Not Follow Guideline Recommendations - A Retrospective Analysis

Objective: This study evaluates the relevance of transfusion guidelines for clinical transfusion practice. Background: There is little data available on current practice related to appropriate use of blood products. Rec...

Clinico-Mycological Pattern of Hair and Skin Infection in New Delhi

Introduction: Fungus parasitizing structures rich in keratin, like hair, skin and nails, lead to a dermal inflammatory response with intense itching and cosmetic disfigurement. Hence, diagnosis, treatment and regional ep...

Individualizing Optimal Fluid Resuscitation in Patients with Major Burns: Emerging Role for Hydrocortisone, Proteinuria and Brain Natriuretic Peptide

During the last decades tremendous progress has been made in the acute resuscitation of patients with major burns [1,2]. The recognition that large amounts of fluids should be infused during the first hours to days, due...

Meaning of Caring from Critical Care Nurses Perspective: A Phenomenological Study

Background: Caring has been known as the inner core and the essence of nursing profession. It seems that critical condition of patients and presence of various and complex technological equipments in critical care units...

Download PDF file
  • EP ID EP301008
  • DOI 10.21767/2471-8505.100096
  • Views 60
  • Downloads 0

How To Cite

Manuel Plomer (2017). More than Expectorant: New Scientific Data on Ambroxol in the Context of the Treatment of Bronchopulmonary Diseases. Journal of Intensive and Critical Care, 3(3), 1-3. https://europub.co.uk./articles/-A-301008